Advanced glycation end products affect cholesterol homeostasis by impairing ABCA1 expression on macrophages.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Canadian Journal of Physiology and Pharmacology

• Publication date

  2017-07-13

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1139/cjpp-2017-0170PMID 28704619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport

  2017cited by this paper
• Paraoxonase 1‐treated oxLDL promotes cholesterol efflux from macrophages by stimulating the PPARγ–LXRα–ABCA1 pathway

  2016cited by this paper
• Glycated Human Serum Albumin Isolated from Poorly Controlled Diabetic Patients Impairs Cholesterol Efflux from Macrophages: An Investigation by Mass Spectrometry

  2015cited by this paper
• Extra Virgin Olive Oil Polyphenols Promote Cholesterol Efflux and Improve HDL Functionality

  2015cited by this paper
• Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population

  2015cited by this paper
• Molecular Mechanisms of Cellular Cholesterol Efflux*

  2014cited by this paper
• Role of AGEs-RAGE system in cardiovascular disease.

  2014cited by this paper
• Extra-virgin olive oil consumption reduces the age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities.

  2013cited by this paper
• Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA‐1‐mediated reverse cholesterol transport

  2013cited by this paper
• Hyperglycemia accelerates ATP‐binding cassette transporter A1 degradation via an ERK‐dependent pathway in macrophages

  2013cited by this paper
• Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models

  2012cited by this paper
• Aging and Atherosclerosis: Mechanisms, Functional Consequences, and Potential Therapeutics for Cellular Senescence

  2012cited by this paper
• Advanced glycation end products

  2012cited by this paper
• Purified human paraoxonase-1 interacts with plasma membrane lipid rafts and mediates cholesterol efflux from macrophages.

  2012cited by this paper
• The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins.

  2012cited by this paper
• D-Galactose Effectiveness in Modeling Aging and Therapeutic Antioxidant Treatment in Mice

  2010cited by this paper
• Dietary Advanced Glycation End Products and Aging

  2010cited by this paper
• High-density lipoprotein heterogeneity and function in reverse cholesterol transport

  2010cited by this paper
• Hyperglycemia and Glycation in Diabetic Complications

  2009cited by this paper
• Age-Associated Decrease of High-Density Lipoprotein-Mediated Reverse Cholesterol Transport Activity

  2009cited by this paper
• Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.

  2008cited by this paper
• Cellular cholesterol efflux to serum is impaired in diabetic nephropathy

  2008cited by this paper
• Aging and glycoxidant stress

  2008cited by this paper
• Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol.

  2008cited by this paper
• Association of apolipoprotein E genotypes with lipid levels and coronary risk.

  2007cited by this paper
• Age-related impairment of HDL-mediated cholesterol efflux.

  2007cited by this paper
• Age-related impairment of HDL-mediated cholesterol efflux Published, JLR Papers in Press, November 8, 2006.

  2007cited by this paper
• Advanced glycation end products: sparking the development of diabetic vascular injury.

  2006cited by this paper
• Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?

  2006cited by this paper
• High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes.

  2005cited by this paper
• D-Galactose injured neurogenesis in the hippocampus of adult mice

  2005cited by this paper
• Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

  2004cited by this paper
• Enhancing reverse cholesterol transport/raising HDL cholesterol: new options for prevention and treatment of cardiovascular disease.

  2004cited by this paper
• Study of factors influencing the decreased HDL associated PON1 activity with aging.

  2004cited by this paper
• Molecular motors

  2003cited by this paper
• Importance of different pathways of cellular cholesterol efflux.

  2003cited by this paper
• Mechanisms of aging: an appraisal of the oxidative stress hypothesis.

  2002cited by this paper
• Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice

  2002cited by this paper
• Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels.

  2001cited by this paper
• Glycation impairs high-density lipoprotein function

  2000cited by this paper
• ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages*

  2000cited by this paper
• Advanced glycation in D-galactose induced mouse aging model.

  1999cited by this paper
• Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.

  1999cited by this paper
• Cell cholesterol efflux: integration of old and new observations provides new insights.

  1999cited by this paper
• Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

  1998cited by this paper
• Inactivation of Cu,Zn-superoxide dismutase by intermediates of Maillard reaction and glycolytic pathway and some sugars.

  1997cited by this paper
• Atherosclerosis and the vascular biology of aging

  1996cited by this paper
• Identification of the Major Site of Apolipoprotein B Modification by Advanced Glycosylation End Products Blocking Uptake by the Low Density Lipoprotein Receptor (*)

  1995cited by this paper
• Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence.

  1994cited by this paper
• Advanced glycosylation end products: A new disease marker for diabetes and aging

  1993cited by this paper
• Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.

  1992cited by this paper
• Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study.

  1992cited by this paper

• Cross-talk between lipopolysaccharide tolerance and AGEs in the regulation of macrophage inflammation and cholesterol efflux.

  2026cites this paper
• Resveratrol prevents gallstones in mice fed on a high fat diet via regulating PPAR-γ and SR-BI

  2025cites this paper
• Comprehensive exploration of marine functional foods in modulation of metabolic syndromes: a 20-year review

  2025cites this paper
• Does AGE-RAGE Stress Play a Role in the Development of Coronary Artery Disease in Obesity?

  2022cites this paper
• A review on shellfish polysaccharides: Extraction, characterization and amelioration of metabolic syndrome

  2022cites this paper
• Aerobic Exercise Training Reduces Atherogenesis Induced by Low-Sodium Diet in LDL Receptor Knockout Mice

  2022cites this paper
• The Susceptibility to Diet-Induced Atherosclerosis Is Exacerbated with Aging in C57B1/6 Mice

  2021cites this paper
• Advanced glycation end products as biomarkers for cardiovascular disease: browning clarifying atherogenesis.

  2020cites this paper
• Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjects.

  2020cites this paper
• Endoplasmic reticulum stress‐dependent autophagy inhibits glycated high‐density lipoprotein‐induced macrophage apoptosis by inhibiting CHOP pathway

  2019cites this paper
• The improvements of functional ingredients from marine foods in lipid metabolism

  2018cites this paper